pharma news today obesity drug glp-1 What is the pipeline for future medications for obesity? Nidhi Joshi | 💉 GLP-1

Although the CR group exhibited significantly lower lumbar spine and hip BMD compared to controls, there were no significant differences in serum CTX, bone-specific alkaline phosphatase (BSAP) levels, or trabecular microarchitecture parameters (e.g., erosion index, surface-to-volume ratio) between the groups

so it is preferred to stick to the doses recommended by your doctor only

Selective inhibition of NF-B activation prevents dopaminergic neuronal loss in a mouse model of Parkinsons disease

When we do a Tummy Tuck, the scar will be a little wider than your C-section scar

We compared the predicted value for each designed peptide with the predicted properties of peptides in the training set within the same potency group